Compare · CBOE vs PHO
CBOE vs PHO
Side-by-side comparison of Cboe Global Markets, Inc. (CBOE) and Invesco Water Resources ETF (PHO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBOE and PHO operate in n/a (n/a), so they compete in similar markets.
- CBOE carries a market cap of $13.01B.
- Over the past year, CBOE is up 10.9% and PHO is down 1.2% - CBOE leads by 12.2 points.
- CBOE has hit the wire 5 times in the past 4 weeks while PHO has been quiet.
- CBOE has more recent analyst coverage (25 ratings vs 0 for PHO).
Cboe Global Markets, Inc.
Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, European Equities, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities; and offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The European Equities segment offers pan-European listed equities transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.
Invesco Water Resources ETF
The investment seeks to track the investment results (before fees and expenses) of the NASDAQ OMX US Water IndexSM (the "underlying index"). The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index seeks to track the performance of companies that create products designed to conserve and purify water for homes, businesses and industries. The underlying index may include common stocks, ordinary shares, American depositary receipts ("ADRs"), shares of beneficial interest and tracking stocks. The fund is non-diversified.
Latest CBOE
- Cboe Global Markets downgraded by Erste Group
- Cboe Global Markets Reports Trading Volume for May 2026
- SEC Form 3 filed by new insider Fischer Heidi
- Cboe Receives SEC Approval to Offer Extended Trading Hours for Select Multi-Listed Single Stock Options
- Cboe Hires Boudewijn Duinstra as Executive Vice President, Chief Risk Officer
- SEC Form 4 filed by SVP, CHIEF ACCOUNTING OFFICER Wilkinson Allen
- Director Froetscher Janet P sold $437,944 worth of shares (1,223 units at $358.09) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 13,807 units (SEC Form 4)
- Cboe Global Markets, Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Mcpeek Jennifer J was granted 530 shares, increasing direct ownership by 9% to 6,368 units (SEC Form 4)
- Director Mansfield Erin was granted 530 shares, increasing direct ownership by 28% to 2,441 units (SEC Form 4)
Latest PHO
- Software Provider Roper Tech Boosts Annual Outlook Following Q1 Performance: The Details
- Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN
- Photocure ASA: Results for the fourth quarter of 2023
- Photocure Partner Asieris Announces New Drug Application Acceptance for Regulatory Review of Hexvix in China
- Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China
- Photocure to present at four investor conferences in November/December 2023
- Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress
- Photocure ASA: Change of Board Composition
- Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint
- Photocure ASA: Results for the second quarter and first half of 2023